Biobank for stroke and related genetic research
CUHK Stroke Biobank
This study is collecting blood and tissue samples from patients to help researchers learn more about the genetic causes of stroke and related diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT03291392 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a biobank of high-quality samples and associated medical data to facilitate future research on stroke, ischemic diseases, and atherosclerosis. Blood, cerebrospinal fluid, and body tissue will be collected from eligible patients, with a focus on understanding the genetic and biological factors contributing to these conditions. The study will also establish operational infrastructure to manage patient consent, sample collection, and data processing, ultimately supporting various research initiatives aimed at improving prevention and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are Chinese adults aged 18 and older who have experienced a stroke or are family members of stroke patients.
Not a fit: Patients who do not have a history of stroke or related conditions may not benefit from participation in this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of stroke and related conditions, leading to improved prevention and treatment options for patients.
How similar studies have performed: Other studies utilizing biobanks for genetic research in stroke have shown promise, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult equal or more 18 years of age and Chinese ONLY. 2. Stroke patients, their family members, and/or the normal subjects without intracranial stenosis or extracranial stenosis, are eligible to join the study. 3. Subject is willing to have blood taken, cerebral spinal fluid and/or body tissue drawn for storage in the research bank. Exclusion Criteria: * None
Where this trial is running
Hong Kong
- Chinese University of Hong Kong — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Thomas Wai Hong LEUNG, FRCP — Chinese University of Hong Kong
- Study coordinator: Thomas Wai Hong LEUNG, FRCP
- Email: drtleung@cuhk.edu.hk
- Phone: 852-35053593
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.